What is iCarbonX?
iCarbonX is at the forefront of digital health innovation, dedicated to creating a comprehensive platform for digitizing, analyzing, and understanding life. By leveraging breakthrough technologies, deep multi-omics data, artificial intelligence, and experiential data, the company aims to deliver transformative products and services. These offerings cater to both partners and consumers, focusing on optimizing individual well-being across various spectrums, including wellness, skincare, fitness, nutrition, prevention, and healthcare management.
How much funding has iCarbonX raised?
iCarbonX has raised a total of $199.8M across 2 funding rounds:
Series A
$154.8M
Private Equity
$45M
Series A (2016): $154.8M with participation from VCANBIO Cell & Gene Engineering Corp., Ltd. and Tencent
Private Equity (2016): $45M led by China Bridge Capital
Key Investors in iCarbonX
China Bridge Capital
China Bridge Capital is an investment management company focused on bridging global disruptive technology companies with the Chinese market, with a significant presence in mobile, cloud, and medical services.
VCANBIO Cell & Gene Engineering Corp., Ltd.
VCANBIO Cell & Gene Engineering Corp., Ltd. operates in precision medicine, focusing on cell and gene engineering to provide comprehensive health management services, including cell therapy and diagnostic materials.
Tencent
Tencent Holdings Limited is a global internet and technology conglomerate providing a wide range of services, including online games, social media, and digital content, with a growing interest in the health sector.
What's next for iCarbonX?
With substantial enterprise-level funding and a recent major strategic investment, iCarbonX is poised for significant expansion and technological advancement. The company's focus on building a robust platform for health data digitization and analysis suggests a strategic direction towards becoming a central hub for personalized health insights. Future developments are likely to involve further integration of AI and multi-omics data to enhance its predictive and preventative health solutions, solidifying its position in the rapidly evolving digital health landscape.
See full iCarbonX company page
